If you're looking for NAD IV therapy near you, Liberty IV has you covered with two clinic locations in Dallas. But that's not all, as they offer even more convenience with their in-home services. With a paramedic response team available, Liberty IV can bring their NAD IV therapy to your doorstep. They even offer same-day EMERGENCY in-home service for an additional $50, making it easier than ever to get the NAD therapy you need.
Liberty IV's NAD IV therapy is a great option for those looking to boost their NAD levels and improve their overall health and longevity. With two clinic locations in Dallas and their in-home services, including same-day in-home service, Liberty IV offers the utmost convenience and flexibility to fit your schedule. Plus, with a paramedic response team, you can trust that you're in safe hands for a smooth and comfortable NAD IV therapy experience.
Michael Lickteig, along with his wife Melissa, built Liberty IV Infusion Therapy to serve the North Texas community. Both Michael and Melissa are Nationally Registered Paramedics licensed in the State of Texas, and both hold National Board Certification as Certified Flight Paramedics. Their careers in emergency medicine span more than a decade working in prehospital emergency 911 and critical care transport, as well as on staff inside some of North Texas’ busiest emergency/trauma units serving both adult and pediatric populations.. Michael holds an MBA from the University of North Texas and Melissa a BS degree from the University of Texas Arlington. The Lickteig family has strong ties to the military and has established partnerships with retired veterans and first responder organizations dedicated to reducing the occurrence of suicide in these vulnerable groups. Their goal is to make care available and affordable to veterans, first responders, or anyone else who is struggling with chronic pain, TBI, or PTSD throughout the North Texas Region.
Michael Lickteig NRP , LP, FP-C, MBA
Melissa Lickteig NRP, LP, FP-C, BS
Sobriety and Satiety: Is NAD+ the Answer?
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Clinical Evidence for Targeting NAD Therapeutically